NCT00436410View on ClinicalTrials.gov

Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

108

Participants

Timeline

Start Date

December 31, 2006

Study Completion Date

August 31, 2009

Conditions

Adrenocortical CarcinomaBreast CancerColorectal CancerGastrointestinal CancerKidney CancerLiver CancerMelanoma (Skin)Ovarian CancerPancreatic CancerSarcoma

Interventions

BIOLOGICAL

colloidal gold-bound tumor necrosis factor

OTHER

electron microscopy

OTHER

pharmacological study

PROCEDURE

conventional surgery

Trial Locations (2)

20892-1182

NCI - Center for Cancer Research-Medical Oncology, Bethesda

20892-1201

NCI - Surgery Branch, Bethesda

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00436410 - Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer | Biotech Hunter | Biotech Hunter